Assembly Biosciences Inc (ASMB)

NASDAQ
Currency in USD
12.340
-0.010(-0.08%)
Closed·
After Hours
12.3400.000(0.00%)
·
ASMB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ASMB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.15812.450
52 wk Range
7.75019.930
Key Statistics
Edit
Prev. Close
12.34
Open
12.4
Day's Range
12.158-12.45
52 wk Range
7.75-19.93
Volume
8.23K
Average Vol. (3m)
28.09K
1-Year Change
-7.84%
Book Value / Share
3.62
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ASMB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
33.500
Upside
+171.47%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Assembly Biosciences Inc Company Profile

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Compare ASMB to Peers and Sector

Metrics to compare
ASMB
Peers
Sector
Relationship
P/E Ratio
−2.3x−0.6x−0.5x
PEG Ratio
−0.06−0.010.00
Price / Book
3.4x2.0x2.6x
Price / LTM Sales
2.9x12.2x2.9x
Upside (Analyst Target)
170.2%332.6%50.4%
Fair Value Upside
Unlock19.0%9.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 33.500
(+171.47% Upside)

Earnings

Latest Release
Mar 20, 2025
EPS / Forecast
-1.58 / -0.35
Revenue / Forecast
7.36M / --
EPS Revisions
Last 90 days

People Also Watch

15.550
KRRO
-2.69%
125.9300
NUTX
+1.03%
6.8000
FBRX
+8.28%
22.060
TISI
+4.11%
2.430
MLGO
-22.36%

FAQ

What Is the Assembly Biosciences (ASMB) Stock Price Today?

The Assembly Biosciences stock price today is 12.34

What Stock Exchange Does Assembly Biosciences Trade On?

Assembly Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Assembly Biosciences?

The stock symbol for Assembly Biosciences is "ASMB."

What Is the Assembly Biosciences Market Cap?

As of today, Assembly Biosciences market cap is 92.59M.

What Is Assembly Biosciences's Earnings Per Share (TTM)?

The Assembly Biosciences EPS (TTM) is -6.13.

From a Technical Analysis Perspective, Is ASMB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.